litlas
Log inCreate account

Catherine Ledent

Active 1992–2022

80
Papers
19,954
Citations
75
h-index
80
i10-index

Citations

Citations per year for Catherine Ledent1987: 1 citations1988: 15 citations1989: 20 citations1990: 34 citations1991: 34 citations1992: 51 citations1993: 65 citations1994: 61 citations1995: 58 citations1996: 14 citations1997: 21 citations1998: 35 citations1999: 61 citations2000: 72 citations2001: 178 citations2002: 277 citations2003: 295 citations2004: 287 citations2005: 430 citations2006: 365 citations2007: 461 citations2008: 358 citations2009: 363 citations2010: 324 citations2011: 371 citations2012: 218 citations2013: 217 citations2014: 168 citations2015: 189 citations2016: 128 citations2017: 130 citations2018: 120 citations2019: 345 citations2020: 353 citations2021: 345 citations2022: 225 citations2023: 138 citations2024: 221 citations2025: 77 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,286 citing papers, 32.3% of this breakdownItaly: 508 citing papers, 7.2% of this breakdownGermany: 468 citing papers, 6.6% of this breakdownUnited Kingdom: 420 citing papers, 5.9% of this breakdownSpain: 396 citing papers, 5.6% of this breakdownFrance: 373 citing papers, 5.3% of this breakdownCanada: 299 citing papers, 4.2% of this breakdownChina: 254 citing papers, 3.6% of this breakdownJapan: 211 citing papers, 3% of this breakdownSweden: 157 citing papers, 2.2% of this breakdownAustralia: 152 citing papers, 2.2% of this breakdownBrazil: 137 citing papers, 1.9% of this breakdown
0%32.3%Other 20%

Institutions

Fields

  • Medicine51.8%
  • Neuroscience26.5%
  • Biochemistry, Genetics and Molecular Biology17.4%
  • Immunology and Microbiology1.4%
  • Psychology1.4%
  • Nursing0.5%
  • Other1%

Topics

  • Cannabis and Cannabinoid Research14.6%
  • Neuroscience and Neuropharmacology Research11.8%
  • Neurotransmitter Receptor Influence on Behavior7.6%
  • Adenosine and Purinergic Signaling4.2%
  • Sleep and Wakefulness Research4.1%
  • Receptor Mechanisms and Signaling2.8%
  • Other54.9%

Coauthors

All papers

Open in search
  1. Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells

    Authors: Katarzyna Z. Maresz, Gareth Pryce, Eugene D. Ponomarev, Giovanni Marsicano, J. Ludovic Croxford, Leah P. Shriver, Catherine Ledent, Xiaodong Cheng, Erica J. Carrier, Monica Mann, Gavin Giovannoni, Roger G. Pertwee, Takashi Yamamura, Nancy E. Buckley, Cecilia J. Hillard, Beat Lutz, David Baker, Bonnie N. Dittel - Nature Medicine 2007 cited by 362

  2. Expression of members of the putative olfactory receptor gene family in mammalian germ cells

    Authors: Marc Parmentier, F. Libert, Stéphane Schurmans, Serge N. Schiffmann, Anne Lefort, Dominique Eggerickx, Catherine Ledent, Catherine Mollereau, Catherine Gérard, Jason Perret, Anton Grootegoed, Gilbert Vassart - Nature 1992 cited by 408

  3. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis

    Authors: Fatima Teixeira-Clerc, Boris Julien, Pascale Grenard, Jeanne Tran Van Nhieu, Vanessa Deveaux, Liying Li, Valérie Serrière-Lanneau, Catherine Ledent, Ariane Mallat, Sophie Lotersztajn - Nature Medicine 2006 cited by 514

  4. Involvement of CB1 cannabinoid receptors in emotional behaviour

    Authors: Miquel Martín, Catherine Ledent, Marc Parmentier, Rafaël Maldonado, Olga Valverde - Psychopharmacology 2002 cited by 507

  5. Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout Mice

    Authors: Catherine Ledent, Olga Valverde, G Cossu, François Petitet, Jean-François Aubert, F. Beslot, Georg Andrees Böhme, Assunta Impérato, Thierry Pedrazzini, Bernárd P. Roques, Gilbert Vassart, Walter Fratta, Marc Parmentier - Science 1999 cited by 3,614

  6. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy

    Authors: Cyril Laurent, Sylvie Burnouf, Barbara Ferry, Vânia L. Batalha, Joana E. Coelho, Younis Baqi, Enas M. Malik, E Mariciniak, Sandrine Parrot, Ann Van der Jeugd, Émilie Faivre, Vanessa Flaten, Catherine Ledent, Rudi D’Hooge, Nicolas Sergeant, Malika Hamdane, Sandrine Humez, Christa E. Müller, Luı́sa V. Lopes, Luc Buée, David Blum - Molecular Psychiatry 2014 cited by 184

  7. CROCCP2 acts as a human-specific modifier of cilia dynamics and mTOR signaling to promote expansion of cortical progenitors

    Authors: Roxane Van Heurck, Jérôme Bonnefont, Marta Wojno, Ikuo Suzuki, Fausto D. Velez-Bravo, Emir Erkol, Dan Truc Nguyen, Adèle Herpoel, Angéline Bilheu, Sofie Beckers, Catherine Ledent, Pierre Vanderhaeghen - Neuron 2022 cited by 50

  8. Adenosine A 2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function

    Authors: Balázs Csóka, Leonóra Himer, Zsolt Selmeczy, E. Sylvester Vizi, Pál Pacher, Catherine Ledent, Edwin A. Deitch, Z. Spolarics, Zoltán H. Németh, György Haskü - The FASEB Journal 2008 cited by 198

  9. Distribution of CB1 Cannabinoid Receptors in the Amygdala and their Role in the Control of GABAergic Transmission

    Authors: István Katona, Ede Rancz, László Acsády, Catherine Ledent, Ken Mackie, Norbert Hájos, Tamás F. Freund - Journal of Neuroscience 2001 cited by 665

  10. The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A2A receptors

    Authors: Malika El Yacoubi, Catherine Ledent, Jean‐François Ménard, Marc Parmentier, Jean Costentin, Jean‐Marie Vaugeois - British Journal of Pharmacology 2000 cited by 308

  11. CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents

    Authors: József Haller, Balázs Varga, Catherine Ledent, Tamás F. Freund - Behavioural Pharmacology 2004 cited by 242

  12. Modulation of murine dendritic cell function by adenine nucleotides and adenosine: Involvement of the A2B receptor

    Authors: Abduelhakem Ben Addi, Anne Lefort, Xiaoyang Hua, Frédérick Libert, Didier Communi, Catherine Ledent, Pascale Macours, Stephen L. Tilley, Jean‐Marie Boeynaems, Bernard Robaye - European Journal of Immunology 2008 cited by 137

  13. Cannabinoid receptor 1 is a major mediator of renal fibrosis

    Authors: Lola Lecru, Christophe Desterke, Stanislas Grassin‐Delyle, Christos Chatziantoniou, Sophie Vandermeersch, Aurore Devocelle, Amélia Vernochet, N Ivanovski, Catherine Ledent, Sophie Ferlicot, Meriem Dalia, Myriam Saïd, Séverine Beaudreuil, Bernard Charpentier, Aimé Vázquez, Julien Giron‐Michel, Bruno Azzarone, Antoine Dürrbach, Hélène François - Kidney International 2015 cited by 122

  14. The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling

    Authors: Joseph Tam, Victoria Trembovler, Vincenzo Di Marzo, Stefania Petrosino, G. Leo, Alex Alexandrovich, Eran Regev, Nardy Casap, Arie Shteyer, Catherine Ledent, Meliha Karsak, Andreas Zimmer, Raphael Mechoulam, Raz Yirmiya, Esther Shohami, Itai Bab - The FASEB Journal 2007 cited by 198

  15. Cardioprotection by Ecto-5′-Nucleotidase (CD73) and A 2B Adenosine Receptors

    Authors: Tobias Eckle, Thomas Krahn, Almut Grenz, D. Köhler, Michel Mittelbronn, Catherine Ledent, Marlene A. Jacobson, Hartmut Oßwald, Linda F. Thompson, K. Unertl, Holger K. Eltzschig - Circulation 2007 cited by 430

  16. Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice

    Authors: Malika El Yacoubi, Catherine Ledent, Marc Parmentier, Rosalia Bertorelli, Ennio Ongini, Jean Costentin, Jean‐Marie Vaugeois - British Journal of Pharmacology 2001 cited by 197

  17. BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice

    Authors: Ester Aso, Andrés Ozaita, Elsa M. Valdizán, Catherine Ledent, Ángel Pazos, Rafaël Maldonado, Olga Valverde - Journal of Neurochemistry 2007 cited by 187

  18. Involvement of Neuronal Cannabinoid Receptor CB1 in Regulation of Bone Mass and Bone Remodeling

    Authors: Joseph Tam, Orr Ofek, Ester Fride, Catherine Ledent, Yankel Gabet, Ralph Müller, Andreas Zimmer, Ken Mackie, Raphael Mechoulam, Esther Shohami, Itai Bab - Molecular Pharmacology 2006 cited by 160

  19. Metabotropic Glutamate Receptors Drive the Endocannabinoid System in Hippocampus

    Authors: Namita Varma, Gregory C. Carlson, Catherine Ledent, Bradley E. Alger - Journal of Neuroscience 2001 cited by 402

  20. Cannabinoids inhibit neurodegeneration in models of multiple sclerosis

    Authors: Gareth Pryce, Zubair Ahmed, Deborah J.R. Hankey, Samuel J. Jackson, J. Ludovic Croxford, Jennifer M. Pocock, Catherine Ledent, Axel Petzold, Alan J. Thompson, Gavin Giovannoni, M. L. Cuzner, David Baker - Brain 2003 cited by 341

  21. Endocannabinoid Signaling in Rat Somatosensory Cortex: Laminar Differences and Involvement of Specific Interneuron Types

    Authors: Ágnes L. Bodor, István Katona, Gábor Nyíri, Ken Mackie, Catherine Ledent, Norbert Hájos, Tamás F. Freund - Journal of Neuroscience 2005 cited by 330

  22. Regulation of Extracellular Signal-Regulated Kinase by Cannabinoids in Hippocampus

    Authors: Pascal Derkinderen, Emmanuel Valjent, Madeleine Toutant, Jean‐Christophe Corvol, Hervé Enslen, Catherine Ledent, James M. Trzăskos, Jocelyne Caboche, Jean‐Antoine Girault - Journal of Neuroscience 2003 cited by 325

  23. Context‐dependent effects of CB1 cannabinoid gene disruption on anxiety‐like and social behaviour in mice

    Authors: József Haller, Balázs Varga, Catherine Ledent, István Barna, Tamás F. Freund - European Journal of Neuroscience 2004 cited by 285

  24. GPR3 Receptor, a Novel Actor in the Emotional-Like Responses

    Authors: Olga Valverde, Evelyne Célèrier, Mária Baranyi, Pierre Vanderhaeghen, Rafaël Maldonado, Beáta Sperlágh, Gilbert Vassart, Catherine Ledent - PLoS ONE 2009 cited by 79